Skip to main content

TruGenomix, a Veteran-Led Biotech Instrumental in Early Identification & Awareness of PTSD, Raises $1.8 Million Seed Round, Led by Sanford Health & Viking Global

By September 8, 2020News
NewImage

NewImage

TruGenomix recently announced $1.8 million in financing in a seed round led by Sanford Health. The startup, a graduate of the Illumina Accelerator program and a Veteran Founder Initiative company, also announced matching funding from Viking Global, a partner of the Illumina Accelerator.

As a veteran-owned business, TruGenomix’s founding mission of improving the lives of U.S. military service members and veterans remains at its roots. With a vision of bringing behavioral health into the 21st century, TruGenomix is advancing the diagnosis of post-traumatic stress disorder (PTSD) through leveraging genomic and machine learning technologies.

Image: https://fi.co

{iframe}https://fi.co/insight/trugenomix-raises-1-8-million-seed-round-led-by-sanford-health-viking-global{/iframe}

Leave a Reply

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.